Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03842579
Other study ID # S-20180048
Secondary ID S-20180048
Status Recruiting
Phase N/A
First received
Last updated
Start date February 13, 2019
Est. completion date June 1, 2021

Study information

Verified date May 2020
Source University of Southern Denmark
Contact Sussi F. Buhl, PhD.Stud
Phone +45 65 50 89 24
Email sbuhl@health.sdu.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the effects of interventions with high-protein diet alone or in combination with resistance training on muscle mechanical function (muscle power and strength), frailty status, functional performance, muscle mass and quality of life.


Description:

Study design: two-phase randomized controlled trial with three arms.

Phase 1 stabilization phase lasting one month. Participants with low protein intake (<1.0 g/kg/day) are provided with national guidelines for daily protein intake and publicly available information material and recommended to increase their protein intake to meet the guidelines. Compliance to the recommendation/ guidelines (eating >1.0 g/kg/day) will be evaluated by 4-day food records at the end of the stabilization phase. Only compliant participants are eligible for phase 2. Participants that are not compliant will be followed as "natural observational group" but will not be considered for the primary statistical analysis. Data collection in these participants will only include assessment of selected demographic, functional and nutritional parameters and semi-structured interviews to identify potential barriers for not improving protein intake. Semi-descriptive data will be presented if possible.

Phase 2: Three-arm randomized controlled trial lasting four months:

i) Protein-only (PROT): participants will receive milk-based protein-rich products with the aim of targeting a daily protein intake of 1.5 g/kg; ii) Exercise and Protein (EXEPROT): participants will receive the protein intervention as in the PROT-group combined with progressive explosive type heavy-resistance strength training two times per week iii) Recommendations (REC) participants receive the national nutritional recommendations for older adults and are recommended to follow these recommendations over the course of the study.

Nutritional data will be collected pre and post the stabilization phase. Collection of the primary and secondary outcomes will occur at baseline (pre phase 2) and at the 4-month follow-up (post phase 2). Nutritional assessment will also be evaluated halfway, at the 2-month follow-up.

Compliance Adherence to the exercise protocol and protein supplementation is recorded during the study. For the exercise protocol adherence will be considered as achieving minimum to 75% of valid training sessions, considered as minimum 70% of the exercises planned for each session. For the protein supplementation, adherence will be evaluated as daily protein intake of ≥ 1.35 g/kg (estimated from 24 hours recall and four-day food records) at the 2-month follow-up and at the 4-months follow-up. Compliance will also be estimated from during each delivery of products with a set of questions (e.g. how much of the supplement is consumed? Any changes to the habitual food intake?) and regular phone follow-ups. If participants are unable to reach the protein target additional face to face or phone interview will be planned to support adherence. For the REC-group adherence is defined as following the recommended intake of protein (1.0-1.3 g/kg/day).

Sample size and statistics Lower leg muscle power is the primary outcome of this study. Due to lack of studies similar to this study design (e.g. age and frailty status of the participants, type of exercise and level of protein supplementation) the investigators have calculated sample size using a combination of studies and methods. Based on findings from a 2017 study the effect of 12-weeks of protein supplementation (two daily supplements of 20 g milk protein) in combination with resistance training in +80-year-old healthy adults increased muscle power by 15% (SEM ± 5%) in comparison with -7% (SEM ± 6%) in the control group (receiving protein supplementation only). A result from a 2018 study indicate that 12 weeks of nutritional supplementation (0.8 g/kg/day, 1.2 g/kg/day or 1.5 g/kg/day) to pre-frail or frail older adults >70 years resulted in an increase in muscle mass (estimated by Dual energy X-ray Absorptiometry, DXA) of approximately 4% in the group receiving 1.5 g/kg/day. Unpublished data from the investigators research group show that change in muscle mass (estimated by DXA) accounted for 1,95% of the change in muscle power in older adults following 12 weeks of resistance training. Hence, the estimated effect of an increase in muscle mass of 4% on muscle power is 7,8%. Adding this to the results from the 2017 study gives an estimated change on 0,8% in the PROT-group. Assuming, that the change in muscle mass are comparable in the three groups the investigator therefore expect a change in muscle power of 15%, 0,8% and -7% with a standard deviation (SD) of 30 in the EXEPROT-, PROT- and REC-group, respectively.

Setting a power of 0.8 sample size with 37 participants in each arm should be enough to detect a significant difference in muscle power (significance level at 0.05). Adding 25% to account for dropouts a total of 150 participants is needed.

Intention-to-treat analysis will be performed. In addition, per-protocol analysis of participants that are compliant to the protocol will be performed.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date June 1, 2021
Est. primary completion date June 1, 2021
Accepts healthy volunteers No
Gender All
Age group 80 Years and older
Eligibility Inclusion Criteria:

- Community-dwelling adults = 80 years

- Pre-frail or frail (evaluated by the physical frailty questionnaire, SHARE-FI75+)

- Intact cognitive function (Mini Mental State Evaluation =4)

- Medically stable evaluated by medical screening including blood sample

- Able to participate in group-based exercise without personal assistance

- Able to understand, read and write Danish

Exclusion Criteria:

- Allergic/ intolerant to the interventions (kidney diseases, lactose intolerance etc.)

- On a weight losing diet

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Resistance training
Supervised progressive explosive type heavy-resistance training two times per week
High-protein diet
Daily supplementation with milk-based protein-rich products
Recommendations
Provided with the official national recommendations on nutrition

Locations

Country Name City State
Denmark University of Southern Denmark Odense

Sponsors (4)

Lead Sponsor Collaborator
University of Southern Denmark Arla Foods, Metropolitan University College, Municipality of Odense, Denmark

Country where clinical trial is conducted

Denmark, 

References & Publications (2)

Bechshøft RL, Malmgaard-Clausen NM, Gliese B, Beyer N, Mackey AL, Andersen JL, Kjær M, Holm L. Improved skeletal muscle mass and strength after heavy strength training in very old individuals. Exp Gerontol. 2017 Jun;92:96-105. doi: 10.1016/j.exger.2017.03.014. Epub 2017 Mar 28. — View Citation

Park Y, Choi JE, Hwang HS. Protein supplementation improves muscle mass and physical performance in undernourished prefrail and frail elderly subjects: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2018 Nov 1;108(5):1026-1033. doi: 10.1093/ajcn/nqy214. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Cognitive function The Digit Symbol Substitution Test Baseline and 4-months follow-up
Other Gender Gender (male female) Baseline
Other Age Age (years) Baseline
Other Education Self-report education will be assessed as number of years spent in school and maximum level of education achieved. Baseline
Other Marital status Marital status will be evaluated as self-report. Baseline
Other Depression depression will be evaluated with validated questionnaire at baseline (Geriatric Depression Baseline
Other Incontinence Incontinence will be evaluated with the International Consultation on Incontinence Questionnaire (ICIQ) questionnaire at baseline (max score 21) Baseline
Other Chronic conditions Number and type of chronic conditions will be assessed as self-report Baseline
Other Use of medicine Direct count of name and dose of medicines performed under medical screening. The participant will be asked to bring the medicines. Baseline
Primary Changes from baseline lower leg muscle power at 4 months Lower leg muscle power will be assessed unilaterally using the Nottingham Leg Rig Baseline and 4-month follow-up
Secondary Changes from baseline physical frailty status at 4 months Changes in frailty status will be evaluated by the physical frailty questionnaire (SHARE-FI75+) and the slightly modified version of the Frailty Phenotype assessment tool developed by Fried. Baseline and 4 months follow-up
Secondary Changes from baseline countermovement jump muscle power at 4 months Weight-bearing multi-joint motor task, countermovement jump, with a linear encoder. Baseline and 4-month follow-up
Secondary Changes from baseline leg press and handgrip muscle strength at 4 months Lower limb muscle strength will be measured during a maximal voluntary isometric leg press test (MVC). Subjects are seated in a custom-built unilateral leg press device (knee and ankle angles of 120 and 90, respectively) while pushing against a fixed instrumented force plate as hard and fast as possible with the dominant leg against. Muscle strength, contractile Rate of Force Development (RFD) and impulse will be determined in the trial with the highest resultant peak force.
Handgrip: Maximal isometric handgrip strength will be assessed unilaterally using a handheld dynamometer
Baseline and 4-month follow-up
Secondary Changes from baseline Short Physical Performance Battery test at 4 months Physical function will be measured with the Short Physical Performance Battery (SPPB) which consists of three items (balance, 3 or 4 meters walking and repeated chair rise). Score ranges from 0-12 (each item has a score between 0 and 4). Baseline and 4-month follow-up
Secondary Eating Symptom Questionnaire Evaluated by a validated eating ability questionnaire. For each symptom participant range from none to severe. Baseline
Secondary Risk of Dysphagia Evaluated by a validated questionnaire, the EAT-10. Resulting in a score ranging from 0-40 Baseline
Secondary Appetite Evaluated by a validated questionnaire the Simplified Nutritional Appetite Questionnaire. Score range from 4-20. Baseline
Secondary Changes from baseline anthropometry waist and hip circumference at 4 months Waist and hip circumference (cm) will be measured using a standard ruler. Baseline and 4 months follow-up
Secondary Changes from baseline body weight at 4 months Body weight will be measured to using a transportable scale. Participants will be measured without shoes and wearing light clothing. Baseline and 4 months follow-up
Secondary Changes from baseline lean and fat mass at 4 months Changes in lean mass and fat mass will be estimated by Bioelectrical Impedance Analysis. Baseline and 4 months follow-up
Secondary Changes from baseline lean and fat mass and bone mineral density) to 4 months Changes in body composition (lean and fat mass and bone mineral density) will be measured by Dual-energy X-ray Absorpmetry. Baseline and 4 months follow-up
Secondary Changes from baseline Health-related quality of life to 4 months Health-related quality of life questionnaires (EQ-5D-3L and SF-12) will be used. Scores range from 11111-33333 and 0-100, respectively. Baseline and 4-months follow-up
Secondary Changes from baseline pain to 4 months Pain will be assessed by validated questionnaires (The brief pain inventory & Back and Neck pain survey questionnaire). Visual analogue scale (score 0-10) is combined with questions about intensity and frequency of pain. Baseline and 4-months follow-up
Secondary Changes from baseline fatigue and fatigability to 4 months Validated questionnaires will be used to assess fatigue and fatigability (Mobility Fatigue, Mob-T, & The Pittsburgh Fatigability Scale). Scores ranging from 0-6 and 0-50, respectively. Baseline and 4-months follow-up
Secondary Changes from baseline activities of daily living to 4 months Activities of daily living will be assessed with self-report questionnaires. Baseline and 4-months follow-up
Secondary Changes from baseline fear of falling to 4 months Validated questionnaire will be used to assess fear of falling (the Falls Efficacy Scale - International). Score range from 16-64. Baseline and 4-months follow-up
Secondary Changes from baseline Blood markers to 4 months Analysis of changes in markers of health and disease will be performed, e.g. Lipid profile, Hormonal profile, protein-markers of inflammation (e.g. High Sensitive C-Reaktivt Protein (HS-CRP), soluble urokinase plasminogen activating receptor (suPAR)), vitamins and minerals. Baseline and 4-months follow-up
Secondary Chenages from baseline Objective measures of Physical activity, sedentary behaviour, nap and sleep to 4 months Accelerometry methodology: level and patterns of physical activity (PA), sedentary behaviour (SB), nap and sleep (NAS) will be assessed with commercially available accelerometers (e.g. Axivity, Actigraph) placed on different anatomic locations (e.g. thigh, hip) for one week. Baseline and 4-months follow-up
Secondary Changes from baseline Self-reported Physical activity & sedentary behaviour to 4 months Self-report questionnaire will be used to assess physical activity and sedentary behaviour (e.g. sedentary behaviour questionnaires). Baseline and 4-months follow-up
Secondary Changes from baseline Dietary intake to 4 month Dietary intake is estimated by Four-day food records and food frequency questionnaires. Protein intake is calculated as average g/day and g/kg/day. Baseline and 4-months follow-up
Secondary 24 hours recall Dietary intake is estimated from 24 hours recall. Protein intake is calculated as average g/day and g/kg/day. pre phase 1
Secondary Changes from baseline Walking speed to 4 months Self-selected and maximal walking speed is measured. Baseline and 4 months follow-up
Secondary Changes from baseline Stand and reach to 4 months The ability to stand and reach is tested Baseline to 4 months follow-up
Secondary Changes from baseline Walking distance to 4 months The distance walked during 2- and 6-minutesis tested. Baseline and 4 months follow-up
Secondary Changes from baseline Upper body ball throwing to 4 months The ability to throw a ball, using the upper body is tested. Baseline to 4 months follow-up
Secondary Changes from baseline Rising from laying position to 4 months the ability to rise from laying position is tested. Baseline to 4 months follow-up
Secondary Changes from baseline Nutritional status to 4 months Nutrititional status is estimated by validated questionnaires: the Mini Nutritional Assessment and Eating Validation Scheme. Scores range from 0-30 and 0-3, respectively. Baseline and 4 months follow-up
Secondary Changes in Risk of poor protein intake to 4 months The questionnaire (protein screener) is used to estimate the probability score of having a low protein intake. Baseline and 4 months
See also
  Status Clinical Trial Phase
Completed NCT02082171 - Multidomain Intervention to Prevent Disability in Elders N/A
Completed NCT00345969 - Exercise and Testosterone Therapy in Elderly Men With Physical Frailty Phase 3
Completed NCT00182949 - Genetics and Epidemiology of Aging Associated Conditions in the Sardinian Population
Active, not recruiting NCT04516642 - Swiss Frailty Network and Repository
Active, not recruiting NCT04235738 - Cognitive Impairment in Older Emergency Department Users and Associated Adverse Outcomes